We elaborate on the diagnostic criteria of SM reported in the most recent 2022 World Health Organization (WHO) classification [6] (Table 2), including sensitive testing methods for detection of activating mutations in the KIT gene or its variants and the diagnostic importance of serum tryptase levels. Here, KIT is linked to systemic mastocytosis.